Literature DB >> 26774111

Hyperuricaemia in patients with type 2 diabetes in a tertiary healthcare centre in sub-Saharan Africa: prevalence and determinants.

Simeon-Pierre Choukem1, Juliette-Amelie Mengue2, Marie-Solange Doualla3, Olivier-Tresor Donfack4, Gerard Beyiha5, Henry N Luma3.   

Abstract

Hyperuricaemia in type 2 diabetes mellitus (T2DM) has been less well investigated in sub-Saharan Africans. Our study of 438 patients found that alcohol intake, body mass index ≥25 kg/m2, hydrochlorothiazide use, statin use, diabetic retinopathy and glomerular filtration rate <60 mL/min/1.73m2 were independently positively associated with hyperuricaemia; whereas smoking reduced this risk. Hyperuricaemia is strongly associated with some modifiable factors, diabetic complications and certain drugs. Our results suggest that further studies should evaluate the potential cost-benefit of screening for hyperuricaemia in type 2 diabetes.
© The Author(s) 2016.

Entities:  

Keywords:  Cameroon; Hyperuricaemia; determinants; prevalence; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 26774111     DOI: 10.1177/0049475515626030

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Uric Acid and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Authors:  Yicong Guo; Siyue Liu; Huilan Xu
Journal:  Front Public Health       Date:  2022-05-31

2.  Active smoking among people with diabetes mellitus or hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Jobert Richie Nansseu; Francky Teddy Endomba; Anderson Ngouo; Jan René Nkeck; Ulrich Flore Nyaga; Arnaud D Kaze; Jean Joel Bigna
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Association between hyperuricemia and glycated hemoglobin in type 2 diabetes at the District Hospital of Dschang.

Authors:  Martial Donkeng; Dieudonné Kuaté; Patrice Nzogang Koudjou; Jean Jacques Noubiap; Jules Roger Kuiate
Journal:  Pan Afr Med J       Date:  2021-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.